|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs | |||||
| Amortization of above/below-market assumed debt | |||||
| Noncash revenue adjustments | |||||
| Amortization of deferred losses (gains) on interest rate swaps | |||||
| Stock-based compensation expense | |||||
| Gain on sales of real estate, net | |||||
| Provisions for impairment | |||||
| Loss on debt extinguishment | |||||
| (Gain) loss on involuntary conversion of building and improvements | |||||
| Changes in assets and liabilities, net of assets acquired and liabilities assumed: | |||||
| Other assets, net | |||||
| Accounts payable, accrued expenses, and other liabilities | |||||
| Lease incentive payments | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisitions of real estate | |||||
| Real estate development and improvements | |||||
| Investment in mortgage loans receivable | |||||
| Principal collections on mortgage loans receivable | |||||
| Proceeds from sale of mortgage loans receivable | |||||
| Earnest money deposits | |||||
| Purchase of computer equipment and other corporate assets | |||||
| Proceeds from sale of real estate | |||||
| Proceeds from the settlement of property-related insurance claims | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Issuance of common stock in public offerings, net | |||||
| Payment of common stock dividends | |||||
| Payment of OP unit distributions | |||||
| Payment of restricted stock dividends | |||||
| Principal payments on mortgages payable | |||||
| Proceeds under revolving credit facilities | |||||
| Repayments under revolving credit facilities | |||||
| Proceeds from term loans | |||||
| Proceeds under property development incentives | |||||
| Principal payments on term loans | |||||
| Repurchase of common stock for tax withholding obligations | |||||
| Payment of deferred offering costs | |||||
| Payment of deferred financing costs | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of the period | |||||
| Cash, cash equivalents, and restricted cash at end of the period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest, net of amounts capitalized | |||||
| Cash (received) paid for income taxes, net | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Dividends declared and unpaid on restricted stock | |||||
| Deferred offering costs included in accounts payable, accrued expenses, and other liabilities | |||||
| Loan Origination Fees On Mortgage Loans Receivable, Accrued Not Yet Received | |||||
| Cash flow hedge change in fair value | |||||
| Mortgage loan receivable settled in exchange for acquisition of real estate | |||||
| Increase in mortgage loan receivable in exchange for disposition of real estate | |||||
| Refinancing of mortgage loan receivable | |||||
| Mortgage note assumed at fair value | |||||
| Involuntary conversion of building and improvements and change in related insurance proceeds receivable | |||||
| Operating lease right-of-use asset and liability added for corporate office, excluding $0.9 million non-cash lease incentive received | |||||
| Accrued capital expenditures and real estate development and improvement costs | |||||
| Accrued lease incentives | |||||
Loading...